Diagnostic hapten-carrier conjugates BSA-hyaluronic acid (HA), OVA-hyaluronic acid (HA), KLH-hyaluronic acid (HA) for Liver diseaseHA detection in Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.

Cat:GMP-SMT-HA-Ag
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
SKU GMP-SMT-HA-Ag Categories , , Tag

Product Details

Hyaluronic acid, also known as hyaluronan, is a clear, gooey substance that is naturally produced by your body. The largest amounts of it are found in your skin, connective tissue and eyes. Its main function is to retain water to keep your tissues well lubricated and moist.Genemedi produces core diagnostic ingredients for test of Liver disease and related syndrome.

GeneMedi offers Diagnostic hapten-carrier conjugates BSA-hyaluronic acid (HA), OVA-hyaluronic acid (HA), KLH-hyaluronic acid (HA) for Liver disease HA detection in Competitive immunoassay validation (Competitive ELISA), Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Liver disease test are suitable for in functional ELISA, and other immunoassays in dignostics.

Product Description

Cat No.
GMP-SMT-HA-Ag
Product Name
BSA-hyaluronic acid (HA) / OVA-hyaluronic acid (HA)
Expression platform
Synthetic
Bioactivity validation
hyaluronic acid (HA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HA level test of Liver diseases and related syndrome evaluation
Products description
Competitive immunoassay-validated hapten-carrier conjugates BSA-hyaluronic acid (HA) / OVA-hyaluronic acid (HA) is Synthetic.
Purity
Application
Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation
Lyophilized from sterile PBS, PH 7.4
Storage
Store at  -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Cat No.
GMP-SMT-HA-Ag
Product Name
Expression platform
Isotypes
Bioactivity validation
Tag
Products description
Specics
Purity
Application
Formulation
Storage
Genemeidi Omicron Variant Products
test
Previous slide
Next slide

Diagnostic antibodies and antigens for Epilepsy-related valproate (VPA) toxicity testing: Sodium valproate (VPA)

Valproate is a commonly used antiepileptic drug for the treatment of epilepsy and seizures. It is safe for use in both adults and children more than three years of age. Valproate toxicity can occur both accidentally and intentionally. Acute valproate overdose usually presents with CNS depression/encephalopathy, electrolyte abnormalities such as hypernatremia, elevated transaminase levels, hyperammonemia, and hepatoxicity. In patients with a severe overdose of valproate, patients can present with hypotension, tachycardia, respiratory depression, metabolic acidosis, cerebral edema, and valproate-related hyperammonemic encephalopathy which may progress to coma and death. GENEMEDI developed the Gastrin-17 (G-17) antigens and antibodies for the diagnosis of valproate toxicity based on ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.